science_technology_and_other_research_and_development · DOD-AMRAA

DoW Melanoma Research Program Survivorship Research Award

Defense Health Agency Contracting Activity - DHACA · HT942526MRPSRA

49 days left

Total Program Funding

$2.0M

Expected Awards

Deadline

October 14, 2026

GRANTQUICK SUMMARYPlain-English Overview

DoD Melanoma Research Program Survivorship Research Award funds 2 grants for research improving quality of life and long-term outcomes for melanoma survivors.

Who Should Apply

Researchers studying melanoma survivorship — late effects, surveillance, psychosocial outcomes, or recurrence prevention.

Who Should NOT Apply

Researchers focused on primary treatment/diagnosis without survivorship angle.

Key Requirements (Plain English)

•Must address melanoma survivorship
•2 awards
•Must improve survivor outcomes

💡 GrantQuick Tip

Melanoma survivorship includes: surveillance anxiety, immunotherapy long-term effects, and second primary prevention. Address what survivors face AFTER treatment.

Competitiveness: Moderate-high — 2 awards in survivorship research.

What This Grant Funds

Summary: The fiscal year 2026 (FY26) Melanoma Research Program (MRP) Survivorship Research Award addresses the relatively new and underfunded area of melanoma-specific survivorship by supporting a broad range of innovative and impactful research that has the intended outcome of improving the health and well-being of melanoma survivors, their families and/or their care partners in the near term. Proposed studies focusing exclusively on animal models or considering survival only without consideration of quality of life, overall health and/or function are not responsive to this funding opportunity.

Distinctive Features:

· The application must include at least one melanoma consumer collaborator, defined as a melanoma survivor, family member and/or care partner who can provide lived experience expertise to the research project team, or a melanoma-community supporting organization to support the planning, execution, and implementation of the proposed research.

· Clinical trials are allowed.